Fig. 3
From: Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
CT-scan, left sided thyroid tumor; A initial situation, tumor size 65 × 37 mm. B postoperative status on day 20; tumor size 44 × 26 mm. C status 2 months after initiation of vemurafenib; tumor size 35 × 22 mm. D status 5 months after initiation of vemurafenib; tumor size 33 × 16 mm. E status 7 months after initiation of vemurafenib; tumor size 33 × 16 mm